Literature DB >> 2137512

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

F R Carbone1, M J Bevan.   

Abstract

MHC class I-restricted T lymphocyte responses are usually directed to cellular antigenic components resulting from endogenous gene expression. Exogenous, non-replicating antigens, such as soluble proteins, usually fail to enter the class I pathway of antigen processing and presentation. Consistent with this notion, we have recently shown that soluble, exogenous proteins can be efficiently processed for class I presentation in vitro only if they are introduced directly into the target cell cytoplasm. In this report we extend this work to the in vivo situation by introducing soluble protein into the cytoplasm of mouse splenocytes via the osmotic lysis of pinosomes and then using these cells for in vivo immunization. Our results show that cytoplasmic loading of OVA and beta-GAL into H-2b and H-2d splenocytes respectively, resulted in effective in vivo immunogens for class I-restricted CTL. To our surprise, control spleen cell preparations simply incubated with the exogenous, native protein for 10 min at 37 degrees C in isotonic medium and then washed could also induce a comparable class I-restricted CTL response following intravenous injection. Experiments using (H-2b X H-2d)F1 mice showed that protein pulsed splenocytes from one parental strain could effectively "cross prime" T cells restricted to the MHC of the other parental strain. In all cases, target cell recognition by the effector CTL generated by immunization with spleen cell-associated antigen required the antigen to be present in the cell cytoplasm. Thus the CTL do not recognize target cells exposed to soluble, exogenous antigen. These results, reminiscent of analogous experiments with cross priming by minor histocompatibility antigens, argue that class I-restricted processing and presentation of exogenous antigen can occur in vivo following immunization with cell-associated antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137512      PMCID: PMC2187713          DOI: 10.1084/jem.171.2.377

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.

Authors:  H G Rammensee; H Schild; U Theopold
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

Review 3.  Antigen processing and CD4+ T cell depletion in AIDS.

Authors:  R N Germain
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

4.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

5.  H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.

Authors:  L R Gooding; C B Edwards
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).

Authors:  S S Tevethia; D C Flyer; R Tjian
Journal:  Virology       Date:  1980-11       Impact factor: 3.616

7.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; Y Hosaka
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

8.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

9.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro.

Authors:  R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  109 in total

1.  Ontogeny of T cell tolerance to peripherally expressed antigens.

Authors:  D J Morgan; C Kurts; H T Kreuwel; K L Holst; W R Heath; L A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Getting peptide vaccines to work: just a matter of quality control?

Authors:  Esteban Celis
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.

Authors:  Megan K L MacLeod; Amy S McKee; Alexandria David; Jieru Wang; Robert Mason; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

4.  Mechanism of antigen presentation after hypertonic loading of soluble antigens.

Authors:  Georg A Enders
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

5.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 6.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

7.  Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses.

Authors:  Andreas Zafiropoulos; Eleanor Barnes; Clive Piggott; Paul Klenerman
Journal:  Proc Biol Sci       Date:  2004-02-07       Impact factor: 5.349

8.  Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells.

Authors:  C V Harding; J D Pfeifer
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

9.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.